Nuvectis Pharma, Inc.

NVCT

NVCTNuvectis Pharma, Inc. US flag

NASDAQ Capital Market

9.31

USD

-0.20

- -

246.95MMarket Cap

Income Statement (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Sales/Revenue/Turnover	- -	- -	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	- -	- -	- -
- Operating Expenses	- -	13	19	23	20	28
+ Selling, General & Admin	- -	3	6	8	7	9
+ Research & Development	- -	10	13	15	13	18
+ Other Operating Expense	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	- -	-13	-19	-23	-20	-28
- Non-Operating (Income) Loss	- -	- -	- -	-1	-1	-1
+ Interest Expense, Net	- -	- -	- -	-1	-1	-1
+ Interest Expense	- -	- -	- -	- -	- -	- -
- Interest Income	- -	- -	- -	1	1	1
+ Other Non-Op (Income) Loss	- -	- -	- -	- -	- -	- -
Pretax Income	- -	-13	-19	-22	-19	-26
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	- -	-13	-19	-22	-19	-26
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	- -	-13	-19	-22	-19	-26
- Minority Interest	- -	- -	- -	- -	- -	- -
Net Income, GAAP	- -	-13	-19	-22	-19	-26
- Preferred Dividends	- -	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	- -	-13	-19	-22	-19	-26
EBIT	- -	-13	-19	-23	-20	-28
EBITDA	- -	-13	-19	-23	-20	-28
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -
EBITA	- -	-13	-19	-23	-20	-28
Gross Margin (%)	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -
Sales per Employee	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	13	13	16	17	- -
Basic EPS, GAAP	- -	-1.01	-1.51	-1.43	-1.11	- -
Basic EPS from Cont Ops	- -	-1.01	-1.51	-1.43	-1.11	- -
Diluted Weighted Avg Shares	- -	13	13	16	17	- -
Diluted EPS, GAAP	- -	-1.01	-1.51	-1.43	-1.11	- -
Diluted EPS from Cont Ops	- -	-1.01	-1.51	-1.43	-1.11	- -

Balance Sheet (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Current Assets	- -	6	20	19	19	32
+ Cash, Cash Equivalents & STI	- -	6	20	19	19	32
+ Cash & Cash Equivalents	- -	6	20	19	19	32
+ ST Investments	- -	- -	- -	- -	- -	- -
+ Accounts & Notes Receiv	- -	- -	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	- -
+ Other ST Assets	- -	- -	- -	- -	- -	- -
+ Misc ST Assets	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	- -	1	- -	- -	- -	- -
+ Property, Plant & Equip, Net	- -	- -	- -	- -	- -	- -
+ Property, Plant & Equip	- -	- -	- -	- -	- -	- -
- Accumulated Depreciation	- -	- -	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -	- -	- -
+ Other LT Assets	- -	1	- -	- -	- -	- -
+ Total Intangible Assets	- -	- -	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	1	- -	- -	- -	- -
Total Assets	- -	7	20	19	19	32
+ Payables & Accruals	- -	2	4	3	3	6
+ Accounts Payable	- -	1	3	3	2	6
+ Accrued Taxes	- -	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -
+ Other Payables & Accruals	- -	1	1	- -	1	- -
+ ST Debt	- -	- -	- -	- -	- -	- -
+ ST Borrowings	- -	- -	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	- -	- -	- -
+ Other ST Liabilities	- -	- -	2	4	6	7
+ Deferred Revenue	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	- -	- -	2	4	6	7
Total Current Liabilities	- -	2	6	7	9	13
+ LT Debt	- -	- -	- -	- -	- -	- -
+ LT Borrowings	- -	- -	- -	- -	- -	- -
+ LT Finance Leases	- -	- -	- -	- -	- -	- -
+ Other LT Liabilities	- -	15	- -	- -	- -	- -
+ Accrued Liabilities	- -	- -	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	- -	15	- -	- -	- -	- -
Total Noncurrent Liabilities	- -	15	- -	- -	- -	- -
Total Liabilities	- -	18	6	7	9	13
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -
+ Share Capital & APIC	- -	2	46	66	83	118
+ Common Stock	- -	- -	- -	- -	- -	- -
+ Additional Paid in Capital	- -	2	46	66	83	118
- Treasury Stock	- -	- -	- -	- -	- -	- -
+ Retained Earnings	- -	-13	-32	-54	-73	-100
+ Other Equity	- -	- -	- -	- -	- -	- -
Equity Before Minority Interest	- -	-11	14	12	10	18
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -
Total Equity	- -	-11	14	12	10	18
Total Liabilities & Equity	- -	7	20	19	19	32
Shares Outstanding	12	13	15	17	19	26
Number of Employees	- -	- -	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	- -	- -	- -
Net Debt	- -	-6	-20	-19	-19	-32
Net Debt to Equity	- -	52.16	-140.61	-156.76	-190.81	-171.8
Tangible Common Equity Ratio	- -	-165.36	69.68	63.6	52.2	58.07
Current Ratio	- -	2.41	3.3	2.75	2.09	2.38
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -

Cash Flow Statement (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
+ Net Income	- -	-13	-19	-22	-19	-26
+ Depreciation & Amortization	- -	- -	- -	- -	- -	- -
+ Non-Cash Items	- -	2	2	5	5	6
+ Stock-Based Compensation	- -	2	2	5	5	6
+ Deferred Income Taxes	- -	- -	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	- -	- -	- -	- -	- -
+ Chg in Non-Cash Work Cap	- -	1	4	2	2	4
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	- -	- -	- -	- -
+ Inc (Dec) in Accts Payable	- -	2	4	1	- -	3
+ Inc (Dec) in Other	- -	- -	- -	- -	2	1
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	- -	-10	-14	-16	-12	-16
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	32	5	12	31
+ Increase in Capital Stock	- -	- -	32	5	12	31
+ Decrease in Capital Stock	- -	- -	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	- -	- -	- -
+ Dec in LT Investment	- -	- -	- -	- -	- -	- -
+ Inc in LT Investment	- -	- -	- -	- -	- -	- -
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	- -	- -	- -	- -	- -	- -
+ Dividends Paid	- -	- -	- -	- -	- -	- -
+ Net Cash From Debt	- -	- -	- -	- -	- -	- -
+ Cash From Debt	- -	- -	- -	- -	- -	- -
+ Repayments of Debt	- -	- -	- -	- -	- -	- -
+ Other Financing Activities	- -	15	-4	10	- -	-2
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	- -	15	28	15	12	29
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -	- -
Net Changes in Cash	- -	6	14	-1	-1	13
EBITDA	- -	-13	-19	-23	-20	-28
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -
Free Cash Flow	- -	-10	-14	-16	-12	-16
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-10	-14	-16	-12	-16
Free Cash Flow per Basic Share	- -	-0.75	-1.07	-1.03	-0.72	- -
Price/Free Cash Flow	- -	- -	-7	-8.13	-7.56	- -
Cash Flow to Net Income	- -	0.74	0.71	0.72	0.64	0.61
Capital Expenditures	- -	- -	- -	- -	- -	- -